Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.20    -0.20 (-0.23%)
Bid:
85.50
Ask:
88.00
Spread: 2.50 (2.924%)
Market Cap: £366.55m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Interim Management Statement

14 Apr 2011 07:00

RNS Number : 8629E
PZ CUSSONS PLC
14 April 2011
 



14 April 2011

PZ Cussons Plc

(the "Group")

 

Interim Management Statement

 

PZ Cussons Plc today issues the following interim management statement which covers the period 26th January 2011 to 13th April 2011.

 

Overview of financial performance and position

 

PZ Cussons Plc announces that results for the period have been broadly in line with management expectations, despite challenging trading conditions in some markets and continued high levels of raw material costs.

 

The Group's balance sheet remains healthy with a net funds position and good cash generation during the period.

 

Trading Update

 

Europe

 

In the UK, trading conditions remain challenging with high levels of promotional activity and a continuing squeeze on consumer spending. This is particularly noticeable in areas such as shower gels and handwash. The more premium brands under the newly formed PZ Cussons Beauty division, namely The Sanctuary, St Tropez and Charles Worthington have continued to perform well.

 

Trading conditions in Poland and Greece also remain challenging due to a difficult consumer environment.

 

Asia

 

The Asia region as a whole continues to perform strongly, and whilst the Australian consumer environment has tightened, the relaunch of Cussons Baby in Indonesia is continuing to drive profitable growth.

 

Africa

 

After some initial delays, the Nigerian election process has now begun with the presidential elections expected to be complete by the end of April. Whilst underlying sales rates during the period have improved, some further disruption to trading from the election process is expected during the remainder of the financial year coinciding with the traditionally peak sales months.

 

Exceptional Items

 

These will include transaction costs associated with the acquisition of St Tropez together with further costs associated with the restructuring of the business as anticipated.

 

In addition, exceptional items will include a charge in relation to the enhanced transfer value exercise being conducted in relation to the closed UK based final salary pension schemes and a credit reflecting the change in statutory minimum pension increases from RPI to CPI.

 

Major initiatives

 

In the UK, the formation of the PZ Cussons Beauty division which was announced in February, is on track and expected to be fully operational by 1 June.

 

In Nigeria, initial work on the food and nutrition joint venture with Wilmar International has now begun.

 

Outlook

 

The trading outlook for the remainder of the current financial year remains challenging and is expected to be impacted by the UK trading environment, the temporary delay to Nigeria's election process and continued high levels of raw material costs.

 

These factors will be partially offset by the resilience of our more premium brands in the UK, by the growth in Asia and by the underlying improvement in demand in Nigeria, all of which give cause for encouragement for the next financial year.

 

A further trading update will be made on 9th June 2011 after the close of the financial year.

 

 

Enquiries:

 

PZ Cussons Plc

Brandon Leigh Tel: 0161 435 1016

 

MHP Communications

John Olsen / James White Tel: 020 3128 8100

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDKNDKQBKDFQD
Date   Source Headline
25th Sep 20193:57 pmRNSResult of AGM
25th Sep 20197:00 amRNSAGM Trading Statement
29th Aug 20197:00 amRNSProposed sale of Minerva and Luksja brand
23rd Aug 201912:15 pmRNSPublication of ARA and Notice of AGM
26th Jul 20198:45 amRNSDirector/PDMR Shareholding
23rd Jul 20197:00 amRNSFinal Results
13th Jun 20197:00 amRNSBoard Change
13th Jun 20197:00 amRNSTrading update
30th Apr 20195:30 pmRNSDirector/PDMR Shareholding
18th Apr 20197:00 amRNSTrading Update
28th Mar 201912:15 pmRNSDirector Declaration
14th Mar 201910:00 amRNSPZ Cussons Plc Director Declaration
30th Jan 201911:10 amRNSInterim Dividend Payment Date
29th Jan 20197:00 amRNSHalf-year Report
23rd Jan 20198:10 amRNSDirector Declaration
13th Dec 20187:00 amRNSTrading Update
13th Nov 201811:09 amRNSHolding(s) in Company
26th Sep 20184:25 pmRNSResult of AGM
26th Sep 20187:00 amRNSAGM Trading Statement
6th Aug 20185:30 pmRNSDirector/PDMR Shareholding
30th Jul 20185:19 pmRNSDirector/PDMR Shareholding
26th Jul 20184:05 pmRNSDirector/PDMR Shareholding
26th Jul 20183:15 pmRNSDirector/PDMR Shareholding
24th Jul 20187:00 amRNSFinal Results
14th Jun 20187:00 amRNSTrading update
2nd May 20187:00 amRNSChange to the Board of Directors
15th Mar 20187:00 amRNSTrading Update
30th Jan 20187:00 amRNSInterim Results
4th Jan 20184:41 pmRNSDirectorate Change
14th Dec 20177:00 amRNSTrading Update
7th Dec 201710:42 amRNSHolding(s) in Company
5th Dec 201710:49 amRNSHolding(s) in Company
27th Sep 20175:30 pmRNSAGM Statement
27th Sep 20177:00 amRNSAGM Trading Statement
30th Aug 20175:30 pmRNSDirector/PDMR Shareholding
28th Jul 20175:30 pmRNSHolding(s) in Company
27th Jul 201711:03 amRNSDirector/PDMR Shareholding
25th Jul 20177:01 amRNSBoard Changes
25th Jul 20177:00 amRNSFinal Results
15th Jun 20177:00 amRNSTrading Update
13th Apr 20177:00 amRNSTrading Update
24th Mar 20177:00 amRNSAppointment of Deloitte LLP as Auditor
13th Mar 201712:24 pmRNSDirector/PDMR Shareholding
1st Feb 20178:45 amRNSDirector/PDMR Shareholding
26th Jan 20175:30 pmRNSDirector/PDMR Shareholding
25th Jan 20175:30 pmRNSDirector/PDMR Shareholding
24th Jan 20177:00 amRNSHalf-year Report
15th Dec 20167:00 amRNSTrading Update
12th Oct 20167:00 amRNSAppointment of a new Non-executive Director
3rd Oct 20164:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.